body protection compound - bpc 157 werner science (Body Compound-157) – Limitless Wellness Lab BPC-157 Peptide BPC-157 - Does It

10.1111/jnc.13626 J

Accessed April 21, 2025.

B12 deficiency can mask or coexist with folate deficiency both should be assessed

Patients should undergo a formal metabolic assessment prior to any peptide treatment

William Seeds explains what is happening in his book Peptide Protocols Volume 1: [AOD-9604] is unable to induce dimerization and thereby activation of the receptor (no competition with HGH) This fragment holds the fat-reducing and tissue repair sequence and mimics the effect of HGH on lipid metabolism, without having growth-promoting or pro-diabetic effects [AOD-9604] inhibits lipoprotein lipase activity in adipose tissue, stimulating lipolysis in adipocytes Since AOD-9604 does not interact with growth hormone receptors, it means the peptide has the following advantages over HGH: Does not increase IGF-1 production Does not induce insulin resistance Does not stimulate muscle growth Since beta-3-adrenergic receptor activation appears to be a secondary mechanism of the AOD-9604 peptide, its primary and complete mechanism for fat mobilization and/or fat cell death within adipose tissue is not currently known